14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CRVL vs RYAN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CRVL Captures Overall Composite Edge (42.6 HOLD vs 40.7 SELL), While RYAN Leads 5–0 on Growth & Valuation Pillars
CRVL Overall Winner
6-Pillar Tally: CRVL 0 – 5 RYAN (1 Tie)
Matrix Metrics: CRVL 7 – 3 RYAN
As of Nov 16, 2026, Corvel Corp (CRVL) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (42.6/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 7–3 (led by composite factor balance), while RYAN wins 5–0 across the 6-pillar growth and valuation breakdown. CRVL trades at $87.34 (23.8x Forward P/E, 15.9% operating margin) versus RYAN at $47.86 (19.7x Forward P/E, 19.8% operating margin).
Growth vs. Quality Trade-Off: CRVL earns the overall head-to-head edge with a stronger Unified Composite Score (42.6/100 HOLD vs. RYAN 40.7/100 SELL) and -0.17β · 33% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRVL vs RYAN. Trailing 12-month operating profitability (CRVL 15.9% vs RYAN 19.8%) and valuation multiples (CRVL 23.8x vs RYAN 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 15.9% operating margin.
OpEx & R&D Reinvestment9.6% of Rev ($97M)
90D Engineering Disclosures0 Published
RYAN Moat ProfileScale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $11.9B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment21.3% of Rev ($1.32B)
90D Engineering Disclosures0 Published
Investor FAQ CRVL vs RYAN Key Questions & Quantitative Answers
As of Nov 16, 2026, Corvel Corp (CRVL) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (42.6/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 7–3 (led by composite factor balance), while RYAN wins 5–0 across the 6-pillar growth and valuation breakdown. CRVL trades at $87.34 (23.8x Forward P/E, 15.9% operating margin) versus RYAN at $47.86 (19.7x Forward P/E, 19.8% operating margin). Growth vs. Quality Trade-Off: CRVL earns the overall head-to-head edge with a stronger Unified Composite Score (42.6/100 HOLD vs. RYAN 40.7/100 SELL) and -0.17β · 33% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
RYAN leads the Growth & Scale pillar: CRVL posts +11.5% YoY revenue growth and +24.1% YoY earnings growth on $1.01B TTM revenue (25.5% gross margin, 15.9% operating margin), compared with RYAN at +4.8% YoY revenue growth and +43.1% YoY earnings growth on $6.20B TTM revenue (41.1% gross margin, 19.8% operating margin). On trailing 12-month operating scale, CRVL generates $1.01B in USD-normalized revenue versus $6.20B for RYAN. In operating R&D and SG&A reinvestment, CRVL deploys 9.6% of Rev ($97M) (0 90-day corporate R&D disclosures) versus 21.3% of Rev ($1.32B) (0 disclosures) for RYAN.
RYAN screens cheaper on headline valuation multiples. CRVL trades at 23.8x Forward P/E, 36.0x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (19.3% EBITDA margin), whereas RYAN trades at 19.7x Forward P/E, 58.6x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (28.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRVL (30.6% ROE) versus RYAN (25.1% ROE) capital efficiency.
In options market volatility and institutional positioning, CRVL carries 187.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 33% Vol realized risk). By comparison, RYAN carries 29.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.32β · 39% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.